Marshall Wace
VRCA icon

Marshall Wace’s Verrica Pharmaceuticals VRCA Stock Holding History

Marshall Wace’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$743K Buy
140,497
+55,324
+65% +$354K ﹤0.01% 2277
2025
Q4 		$708K Buy
+85,173
New +$472K ﹤0.01% 2096
2025
Q3 		– Sell
-12,395
Closed -$65.7K – 3454
2025
Q2 		$65.7K Buy
+12,395
New +$66.7K ﹤0.01% 2576
2023
Q3 		– Sell
-5,393
Closed -$311K – 2738
2023
Q2 		$311K Buy
5,393
+4,052
+302% +$246K ﹤0.01% 2130
2023
Q1 		$87.2K Buy
+1,341
New +$81.1K ﹤0.01% 2510
2021
Q3 		– Sell
-3,143
Closed -$355K – 3467
2021
Q2 		$355K Buy
+3,143
New +$381K ﹤0.01% 2271

Other funds holding VRCA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Marshall Wace's VRCA Position: Q1 2026 in Review

Marshall Wace increased its Verrica Pharmaceuticals (VRCA) stake by 65% in Q1 2026, buying an estimated $354K and bringing the position to 140,497 shares worth $743K. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

Marshall Wace first reported a position in VRCA in Q2 2021 and has held it in 6 quarters since. 39 funds tracked by Wall St. Rank hold VRCA as of Q1 2026.

  • Marshall Wace held 140,497 shares of Verrica Pharmaceuticals worth $743K as of Q1 2026.
  • Marshall Wace bought 55,324 Verrica Pharmaceuticals shares in Q1 2026, an estimated $354K.
  • Verrica Pharmaceuticals made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2277 holding.
  • Marshall Wace first reported a position in Verrica Pharmaceuticals in Q2 2021 and has held it in 6 quarters since.
  • 39 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.